Literature DB >> 2177090

The mechanism of the antiherpetic activity of zinc sulphate.

G Kümel1, S Schrader, H Zentgraf, H Daus, M Brendel.   

Abstract

The molecular mechanism of the effects of zinc ions against herpes simplex virus (HSV) infection was investigated. Zinc sulphate (100 microM) in the culture medium of an HSV-infected African green monkey kidney cell line did not block viral DNA synthesis and, at this concentration, only moderate cytotoxic effects were observed in uninfected cells. Nevertheless, virus yields were reduced to less than 1% of the control. Thus the long standing hypothesis that zinc might block multiplication of HSV by selective intranuclear inhibition of the viral DNA polymerase apparently has lost its validity. Inhibition of virus growth in the absence of severe cytotoxicity must therefore result from other effects of ZnSO4. Free virus is inactivated by 15 mM-ZnSO4 within a few hours of its addition. The inactivated virus is defective in the glycoprotein-dependent functions of penetration and, to some extent, adsorption. Electron micrographs show massive deposition of zinc onto virion components. In a virion, transmembrane transport of zinc ions is not expected and the established antiviral effect is therefore explained by an inhibition of virion glycoprotein function after non-specific accumulation of zinc into many virion membrane components.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177090     DOI: 10.1099/0022-1317-71-12-2989

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.

Authors:  José A Fernández-Romero; Ciby J Abraham; Aixa Rodriguez; Larisa Kizima; Ninochka Jean-Pierre; Radhika Menon; Othell Begay; Samantha Seidor; Brian E Ford; Pedro I Gil; Jennifer Peters; David Katz; Melissa Robbiani; Thomas M Zydowsky
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

Review 2.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

3.  A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.

Authors:  Jessica Kenney; Rachel Singer; Nina Derby; Meropi Aravantinou; Ciby J Abraham; Radhika Menon; Samantha Seidor; Shimin Zhang; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; José A Fernández-Romero; Thomas M Zydowsky; Melissa Robbiani
Journal:  AIDS Res Hum Retroviruses       Date:  2012-07-30       Impact factor: 2.205

4.  Zinc salts inactivate clinical isolates of herpes simplex virus in vitro.

Authors:  M Arens; S Travis
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events.

Authors:  G K Geiss; M C An; R E Bumgarner; E Hammersmark; D Cunningham; M G Katze
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo.

Authors:  Jessica Kenney; Aixa Rodríguez; Larisa Kizima; Samantha Seidor; Radhika Menon; Ninochka Jean-Pierre; Pavel Pugach; Keith Levendosky; Nina Derby; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; Gabriela Paglini; Thomas M Zydowsky; Melissa Robbiani; José A Fernández Romero
Journal:  Antimicrob Agents Chemother       Date:  2013-06-10       Impact factor: 5.191

7.  Effect of zinc salts on respiratory syncytial virus replication.

Authors:  Rahaman O Suara; James E Crowe
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

8.  MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1.

Authors:  Olga Mizenina; Mayla Hsu; Ninochka Jean-Pierre; Meropi Aravantinou; Keith Levendosky; Gabriela Paglini; Thomas M Zydowsky; Melissa Robbiani; José A Fernández-Romero
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 5.671

9.  An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques.

Authors:  Jessica Kenney; Meropi Aravantinou; Rachel Singer; Mayla Hsu; Aixa Rodriguez; Larisa Kizima; Ciby J Abraham; Radhika Menon; Samantha Seidor; Anne Chudolij; Agegnehu Gettie; James Blanchard; Jeffrey D Lifson; Michael Piatak; Jose A Fernández-Romero; Thomas M Zydowsky; Melissa Robbiani
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

Review 10.  Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies.

Authors:  Andrea Ries Thurman; Meredith R Clark; Gustavo F Doncel
Journal:  Infect Dis Obstet Gynecol       Date:  2011-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.